DNA Synthesis Market: By Method (Oligonucleotide Synthesis (solid Phase Phosphoramidite Synthesis, Micro-chip Based Oligonucleotide Synthesis), Gene Assembly (Ligation Mediated Assembly, PCR Mediated Assembly), By End-Use (Academic Research Institutes, Biopharmaceutical Companies, and Contract Research Organization), and Geography

DNA synthesis market size was valued at USD 3,702.0 million in 2023 and  is expected to reach USD 10,289.5 million by 2030, and poised to  grow at a CAGR of 18.6% during the forecast year 2024-2030. The DNA synthesis market is driven by the increasing demand for synthetic genes and DNA sequences, growing applications in the agriculture and food industry, and technological advancements. However, the constraints of the DNA synthesis market hinder its growth, which needs to be addressed, the constraints are the high cost of DNA synthesis, intellectual property concerns, regulatory hurdles, synthesis errors, and quality control. The opportunity will contribute to market growth by forensic science used to create synthetic DNA samples, startup breakthroughs in DNA synthesis open new avenues for medical innovation and market growth, and growing demand for personalized medicine.

Strategic funding and innovations transforming the DNA synthesis landscape, emerging commercialized technologies, and adoption of automation with high-throughput technologies are the trends in the market that create demand and the market shows significant growth. North America & Asai-Pacific are the dominant & fastest-growing regions in the DNA synthesis market respectively.  As these technologies improve, the demand for synthetic DNA for research and development increases, further fuelling innovation in DNA synthesis itself. This creates a positive feedback loop that propels advancements in the field of life sciences as a whole. In conclusion, the DNA synthesis market is a critical engine for scientific progress, but it operates within a network of interconnected technologies. Each area fosters advancements in the others, collectively accelerating our understanding and manipulation of the building blocks of life.

DNA Synthesis Market Recent Key Developments:

• In August 2023, Camena Bioscience a cutting-edge synthetic biology company closed a series, a funding round, securing a substantial USD 10 million. This investment reflects the growing demand for DNA synthesis technology.
• In May 2023, GenScript Biotech Corporation unveiled the groundbreaking GenTitan Gene Fragments synthesis service. This service leverages the world’s first and only commercial miniature semiconductor platform, utilizing integrated circuits for high-throughput DNA synthesis.
• On November 9, 2021, Codex DNA, Inc., successfully acquired Eton Bioscience, a privately held provider of synthetic biology products and services. This strategic acquisition enables Codex DNA to expand its commercial offerings, enhance its BioXp system, and reduce raw material costs.